We initially evaluated 174 variables, and then excluded 39 variables with > 30% missing or < 0.2% prevalence. The remaining 135 candidate variables were from structured data in the EHR, including demographics (3) , laboratory values (21), vital signs (5), medications (38), diagnoses and procedures (46), healthcare utilization (14) , cirrhosis etiology (6) , and miscellaneous (2) . In order to obtain a more parsimonious model, we utilized a penalized Cox proportional hazards model, using the L1 penalty (Least Absolute Shrinkage and Selection Operator -LASSO), to select a subset of the predictor variables. 1 Our final model contained 45 variables, determined by the LASSO variable selection procedure. We refer the reader to the appendix for further details regarding the methods and a description of all candidate variables.
The outpatient window comprised of information in the EHR since the patient's last hospitalization (or entry into the study) up until twenty-four hours prior to the patient's next hospitalization/death/or censoring. The inpatient window comprised of information in the EHR twenty-four hours prior to the patient's admission up until time of discharge. For vital signs and laboratory values, the latest available value within the time window was used. Medications were binary indicators, assessed as positive during the outpatient window if the patient had an active prescription at time of admission. Medications were considered positive during the inpatient window if the patient had any instance of that medication administered and documented through bar-coded medication administration during the hospitalization.
Missing values for laboratory tests were imputed using a matrix completion approach based on nonnegative matrix factorization. 2, 3 All variables were used for the imputation, and the R package NNLM was used with the matrix rank of ten. 4 Due to the size of the data, it was computationally intractable to conduct Markov Chain Monte Carlo based multiple imputation. 5 All variable definitions, summary statistics, and missingness are provided in Appendix Tables 1 and 2. LASSO is a form of linear regression designed to both address overfitting and provide variable selection. The LASSO approach shrinks coefficients toward the null value of 0 based on a penalty parameter, lambda, which controls the sum of the model's coefficients. This coefficient "shrinkage" reduces the risk of overfitting the model to the particulars of the training data. Variable selection is achieved when the coefficients of weakly predictive variables are reduced to 0 and the influence of these variables is eliminated from the model. Penalized regression with LASSO is frequently superior to common variable selection methods such as forward/backward selection in many biomedical datasets. 6 Refer to Appendix Figure 1 for a description of our overall model development workflow.
We considered two LASSO models, one generating the lowest error and a second more heavily regularized (i.e. fewer number of variables) model yielding deviance one standard error from the former model. Since the latter afforded a more parsimonious model (117 vs. 45 variables, respectively) with similar predictive performance, we selected the second model for risk prediction. This model contained 45 variables and included demographics (2) , laboratory values (14) , vital signs (5), medications (8), diagnoses and procedures (12) , healthcare utilization (3), and cirrhosis etiology (1) . 
Statistical Analysis
The proportional hazards assumption was verified by plotting the Schoenfeld residuals, and the functional forms of the covariates were assessed using Martingale residuals. 7 Unlike logistic regression, survival models allow us to perform prediction at any post-discharge time point. Harrell's concordance statistic (C-statistic), a global index of model discrimination, serves as a common method of assessing survival model performance. 8, 9 We calculated percentage improvement in the C-statistic using the same calculation as Rajan et. al:
where C-statisticREF is the C-statistic of the MELD, MELD-Na, and CLIF-C AD). 8 The ECI looks at the squared difference between the predicted probability and an estimated observed probability, ranging between 0 and 100, with 0 meaning perfect calibration.
11,12
Since multiple time points exist per patient, bootstrapping was performed by sampling with replacement at the patient level. All time points (in the model building cohort) for selected patients were included in the training set. The validation set for each bootstrap sample consisted of a random admission per patient from the model building cohort. The same validation set was used for all bootstrap samples.
Net Reclassification Index
The Net Reclassification Index (NRI) compares our primary model against each established model with values > 0 indicating improved prediction performance. Performance is shown for two use cases: (a) identifying patients at very low risk of dying, < 5%; and (b) finding very high risk patients, > 40% risk of dying. Our model shows improved overall performance and outcome specific performance (death versus survival). The outcome specific NRI can be interpreted as the change in true positive rate (false positive rate) for predicting death (survival).
When assessing our model's performance at identifying low risk patients (predicted probability of death at 90 days < 5%), the NRI shows significant improvement compared to all three extant models for the CLIF-C AD, MELD, and MELD-Na. The improvement was primarily driven by the model's ability to identify patients who survived. When identifying high risk patients (predicted probability of death at 90 days > 40%), the event specific NRI for high risk patients, i.e. predicting death accurately, was significantly better four our model compared to the CLIF-C AD, MELD, and MELD-Na.
Sensitivity Analyses
Cirrhosis related admissions were defined consistent with prior work 13, 14 as index admissions including a discharge diagnosis of cirrhosis or one of its cardinal complications (spontaneous bacterial peritonitis, varices/variceal bleeding, hepatic encephalopathy, hepatocellular carcinoma, portal hypertension, hepatorenal syndrome, other sequelae of chronic liver disease). Refer to Appendix Table 2 for detailed definitions and procedure codes.
In order to create the bootstrap for the cirrhosis related admission validation, we constructed the bootstrap similarly for the all admissions case as already described. Then we sub-sampled for each bootstrap iteration, admissions related to cirrhosis. Our variable selection pipeline considers 174 distinct variables in our EHR and eliminates variables with very low prevalence or excessive missingness (Step 1, highlighted in figure) . Subsequently we used penalized Cox regression (via LASSO) to perform variable selection (Step 2). LASSO creates separate models with increasing numbers of variables starting with the most important to least important. We selected the LASSO model that sufficiently reduced classification error while still producing a parsimonious model (Step 4). The literature models (MELD, MELD-Na, CLIF-C AD) were then tailored to the VA data via logistic re-calibration (Step 5) and we compared the VA-tailored version of those models with ours (Step 6). Figure 4 : Improvement in prediction accuracy for predicting low probability and high probability of death at ninety days as measured by the Net Reclassification Index.
An NRI > 0 shows improvement compared to the standard model. The event, "Survived or Died," refers to the overall NRI and the events "Survived" and "Died" refer to the event specific NRIs, respectively.
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